Funding Opportunities

Looking to highlight a funding opportunity? Please send a brief description, link, and deadline to communications@massbio.org

State & Federal Programs

NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer  (SBTT) Grants

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (PAR-13-327)

The National Cancer Institute (NCI) announces the availability of a funding opportunity aimed at accelerating the development and commercialization of highly innovative technologies that improve molecular and/or cellular analysis of cancer with a significant likelihood for either overcoming persistent challenges or obstacles or opening entirely new fields for cancer research or clinical care. This Program Announcement complements the goals of the NCI's Innovative Molecular Analysis Technologies (IMAT) program by facilitating a path towards technology commercialization. Prior participation in the IMAT Program is not required for eligibility for this FOA. Applications are expected to indicate the significant attributes and advantages of the proposed technology over currently available technologies and conventional approaches. Click here to learn more.

Receipt Dates: May 28, 2014; November 4, 2014; May 27, 2015; November 4, 2015; May 27, 2016

Additional Opportunities

The New York City American Heart Association Open Innovation Challenge

Deadline: February 20, 2015

Over $25,0000 in prizes and get millions to see your innovation for heart disease and stroke treatment or prevention. Last year's winner IHT Spirit, gained their first million in sales in 2014 and signed a big contract with Adidas just the other day on stage at CES in Vegas. If you have the next big idea in heart healthy ideas, you need to apply today. Next the top teams compete to get the most support for their idea online from patients, providers, Partners, and investors and finally, the top three teams will go on stage in New York at the AHA Innovation and Investment Forum in NYC in front of some of the most active healthcare investors in the world.  

The Michael J. Fox Foundation Rapid Response Innovation Awards

Deadline: No deadline; applications accepted anytime

One-year grants to jump start new ideas in PD research. The Rapid Response Innovation Awards (RRIA) program supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly impact our understanding of Parkinson’s disease.  Moreover, this program is well-suited for early exploratory studies that may open the field up to new targets or pathways that may ultimately feed the early drug development pipeline for a treatment of PD.

Delivering Scientific Innovation for Autism LLC (DELSIA) Product Development Funding

There is no deadline to apply; submit an Expressions of Interest here.

DELSIA is an independent nonprofit venture philanthropy affiliate of the autism research and advocacy foundation Autism Speaks. DELSIA provides funds to for-profit partners to advance the development of products that address unmet medical and behavioral health needs of the autism community. It was created as an innovative funding vehicle with the goal of improving outcomes for individuals with autism spectrum disorder (ASD). DELSIA aims to do this by ensuring that scientific breakthroughs and technological advances are developed into products that improve health and quality of life for individuals with autism and their families. Our purpose is to transform lives by serving as a catalyst to facilitate and accelerate the delivery and availability of impactful products.

 

EvaluatePharma